{"id":293380,"date":"2026-09-09T10:46:08","date_gmt":"2026-09-09T10:46:08","guid":{"rendered":"https:\/\/www.europesays.com\/ro\/293380\/"},"modified":"2026-09-09T10:46:08","modified_gmt":"2026-09-09T10:46:08","slug":"de-ce-aleg-tot-mai-multi-pacienti-occidentali-china-in-locul-sua-pentru-noi-tratamente-impotriva-cancerului-terapia-care-costa-o-avere-in-america-la-jumatate-de-pret-la-shanghai","status":"publish","type":"post","link":"https:\/\/www.europesays.com\/ro\/293380\/","title":{"rendered":"De ce aleg tot mai mul\u021bi pacien\u021bi occidentali China \u00een locul SUA pentru noi tratamente \u00eempotriva cancerului. Terapia care cost\u0103 o avere \u00een America, la jum\u0103tate de pre\u021b la Shanghai"},"content":{"rendered":"<p>Shanghaiul devine o destina\u021bie tot mai c\u0103utat\u0103, datorit\u0103 costurilor mai mici dec\u00e2t \u00een Occident \u0219i progreselor \u00eenregistrate \u00een biotehnologie, scrie The Wall Street Journal.<\/p>\n<p> <img decoding=\"async\" src=\"https:\/\/www.europesays.com\/ro\/wp-content\/uploads\/2026\/09\/1788950768_717_index.jpeg\" alt=\"Spitalele din China, tot mai c\u0103utate de str\u0103ini\" width=\"1125\" height=\"750\" loading=\"eager\" fetchpriority=\"high\" class=\"svelte-1kfbksm\"\/> <\/p>\n<p>Spitalele din China, tot mai c\u0103utate de str\u0103ini Foto: XBeijing Daily @DailyBeijing<\/p>\n<p>publicitate&#8221;); background-position: center center; background-repeat: no-repeat;&#8221;&gt;<\/p>\n<p>Michael Walters, \u00een v\u00e2rst\u0103 de 25 de ani, tocmai \u00ee\u0219i \u00eencepuse primul loc de munc\u0103 cu norm\u0103 \u00eentreag\u0103 dup\u0103 terminarea facult\u0103\u021bii, atunci c\u00e2nd, anul trecut, a fost diagnosticat cu limfom non-Hodgkin, o form\u0103 de cancer al s\u00e2ngelui.<\/p>\n<p>Walters, originar din Noua Zeeland\u0103, a urmat mai multe cicluri de chimioterapie, radioterapie \u0219i imunoterapie la Auckland, f\u0103r\u0103 succes. Medicii i-au vorbit apoi despre terapia CAR-T, o metod\u0103 prin care celulele imunitare ale pacientului sunt extrase, modificate genetic \u00een laborator \u0219i reintroduse \u00een organism pentru a lupta \u00eempotriva celulelor canceroase.<\/p>\n<p>Walters a analizat op\u021biuni din Statele Unite, India \u0219i Australia, unde un spital din Melbourne i-a propus tratamentul \u2014 la un cost de p\u00e2n\u0103 la 600.000 de dolari, o sum\u0103 imposibil de suportat pentru familia sa.<\/p>\n<p>La Spitalul SinoUnited din Shanghai, Walters a pl\u0103tit mai pu\u021bin de jum\u0103tate din aceast\u0103 sum\u0103, iar pe 18 august a aflat c\u0103 tratamentul reu\u0219ise s\u0103 aduc\u0103 limfomul \u00een remisie complet\u0103.<\/p>\n<p>\u201eM\u0103 simt mult mai recunosc\u0103tor pentru via\u021b\u0103\u201d, a declarat Walters. \u201eDac\u0103 ar fi fost acum 10 sau 15 ani, nu a\u0219 fi avut aceast\u0103 op\u021biune.\u201d<\/p>\n<p>Terapia CAR-T, prescurtarea de la \u201eterapia cu celule T cu receptori antigenici chimeri\u201d, a fost dezvoltat\u0103 pentru prima dat\u0103 \u00een SUA. Ast\u0103zi, \u00eens\u0103, Shanghaiul se impune ca o destina\u021bie preferat\u0103 pentru pacien\u021bii din America \u0219i din alte \u021b\u0103ri bogate, o dovad\u0103 nu numai a costurilor reduse din China, ci \u0219i a ascensiunii \u021b\u0103rii ca actor inovator \u00een domeniul biotehnologiei.<\/p>\n<p>\u201eChina a f\u0103cut, practic, cu terapia CAR-T ceea ce a f\u0103cut \u0219i cu alte industrii: a industrializat-o\u201d, a declarat Sairah Ahmed, directoarea programului CAR-T din cadrul departamentului de limfom \u0219i mielom de la MD Anderson Cancer Center, Universitatea din Texas, Houston.<\/p>\n<p> \u00cen unele cazuri, China a dep\u0103\u0219it chiar Statele Unite <\/p>\n<p>\u00cen iunie, autorit\u0103\u021bile de reglementare de la Beijing au aprobat un tratament CAR-T pentru cancerul de stomac \u0219i de intestin sub\u021bire superior &#8211; prima terapie CAR-T aprobat\u0103 la nivel mondial pentru tumori solide, noteaz\u0103 WSJ.<\/p>\n<p>publicitate&#8221;); background-position: center center; background-repeat: no-repeat;&#8221;&gt;<\/p>\n<p>Josh Bronkhorst, \u00een v\u00e2rst\u0103 de 59 de ani, director executiv al unei companii de servicii financiare, a fost printre primii pacien\u021bi care au beneficiat de tratament dup\u0103 aprobare. Diagnosticat \u00een decembrie, acesta a urmat patru luni de chimioterapie \u0219i imunoterapie, doar pentru a constata c\u0103 tumora continua s\u0103 creasc\u0103.<\/p>\n<p>Medicii i-au spus c\u0103 un nou ciclu de chimioterapie ar avea doar 15% \u0219anse de reu\u0219it\u0103. Astfel, Bronkhorst, \u0219i el neozeelandez, a plecat spre China.<\/p>\n<p>\u201e\u00cen fiecare zi m\u0103 simt pu\u021bin mai bine\u201d, a declarat Bronkhorst, cu o voce slab\u0103, pe 6 august, din patul s\u0103u de la Spitalul Interna\u021bional Jiahui din Shanghai. La zece zile dup\u0103 ce celulele modificate genetic \u00eei fuseser\u0103 introduse \u00een organism, acumularea de lichide cauzat\u0103 de cancer se oprise, permi\u021b\u00e2nd medicilor s\u0103 \u00eei \u00eendep\u0103rteze tubul de drenaj.<\/p>\n<p>\u201eNu este un medicament miraculos, dar a fost, de departe, cea mai bun\u0103 op\u021biune pe care am g\u0103sit-o\u201d, a spus el la acel moment.<\/p>\n<p>Pe 16 august, s-a \u00eentors cu avionul \u00een Noua Zeeland\u0103, unde continu\u0103 s\u0103 \u00ee\u0219i revin\u0103.<\/p>\n<p>Ahmed, de la MD Anderson, a spus c\u0103 le-a recomandat unora dintre pacien\u021bii s\u0103i din afara SUA s\u0103 caute tratament \u00een China, unde terapia CAR-T poate costa \u00eentre 150.000 \u0219i 230.000 de dolari, fa\u021b\u0103 de 550.000 p\u00e2n\u0103 la 850.000 de dolari \u00een Statele Unite.<\/p>\n<p>Autorit\u0103\u021bile de reglementare din zeci de \u021b\u0103ri au aprobat terapia CAR-T pentru cancerele s\u00e2ngelui, printre care leucemia, limfomul \u0219i mielomul. Tratamentele primite de Bronkhorst \u0219i Walters se num\u0103r\u0103 printre cele nou\u0103 produse CAR-T aprobate de autorit\u0103\u021bile chineze \u2014 cel mai mare num\u0103r la nivel mondial.<\/p>\n<p>publicitate&#8221;); background-position: center center; background-repeat: no-repeat;&#8221;&gt;<\/p>\n<p>Tratamentul pentru cancerul de stomac administrat lui Bronkhorst a fost dezvoltat de compania CARsgen Therapeutics, cu sediul la Shanghai, care a ob\u021binut aprobarea autorit\u0103\u021bilor chineze pentru terapia CAR-T destinat\u0103 tumorilor solide, \u00een urma unui program de studii clinice care a inclus \u0219i pacien\u021bi americani trata\u021bi la MD Anderson \u0219i la Clinica Mayo din Minnesota.<\/p>\n<p> \u201eAvem tot mai multe arme noi \u00een lupta \u00eempotriva cancerului\u201d <\/p>\n<p>\u201eAvem tot mai multe arme noi \u00een lupta \u00eempotriva cancerului\u201d, a declarat \u00eentr-un interviu Li Zonghai, fondatorul \u0219i directorul executiv al CARsgen. \u201eMul\u021bi spuneau c\u0103 nu poate fi tratat, iar acum apar tot mai multe metode, at\u00e2t de multe op\u021biuni de tratament.\u201d<\/p>\n<p> <a class=\"related-inline svelte-78g0vl\" data-gtrack=\"{&quot;event&quot;:&quot;utm_click&quot;,&quot;data&quot;:{&quot;event_category&quot;:&quot;article_related&quot;}}\" href=\"https:\/\/adevarul.ro\/economie\/cum-se-va-reconfigura-economia-globala-in-doar-2552946.html\" title=\"Alt articol de interes pentru tine\" rel=\"nofollow noopener\" target=\"_blank\"> Cum se va reconfigura economia global\u0103 \u00een doar c\u00e2\u021biva ani \u0219i unde se plaseaz\u0103 Rom\u00e2nia <\/a><\/p>\n<p>\u00cen ciuda progreselor \u00eenregistrate, China s-a confruntat \u0219i cu controverse legate de transparen\u021ba studiilor clinice, dup\u0103 ce trei persoane, printre care o feti\u021b\u0103 de 6 ani, ar fi murit \u00een timp ce urmau tratamente experimentale. \u00cen general, autorit\u0103\u021bile chineze permit spitalelor s\u0103 demareze studii clinice cu o supraveghere guvernamental\u0103 central\u0103 mai redus\u0103 dec\u00e2t cea impus\u0103 \u00een Statele Unite &#8211; un sistem care a stimulat inova\u021bia, dar a crescut \u0219i riscurile pentru pacien\u021bii inclu\u0219i \u00een astfel de studii.<\/p>\n<p>\u00cen schimb, spitalele private interna\u021bionale din China au adoptat, \u00een general, o abordare mai prudent\u0103, evit\u00e2nd studiile clinice \u0219i limit\u00e2ndu-se la terapii &#8211; inclusiv tratamente CAR-T &#8211; deja aprobate de autorit\u0103\u021bile de reglementare pentru comercializare.<\/p>\n<p>Folosirea sistemului imunitar pentru a ataca celulele canceroase st\u0103 la baza multora dintre progresele medicale ale acestui secol, iar ritmul inova\u021biei se accelereaz\u0103.<\/p>\n<p>publicitate&#8221;); background-position: center center; background-repeat: no-repeat;&#8221;&gt;<\/p>\n<p>\u00cen august, compania Moderna, cu sediul \u00een Cambridge, statul Massachusetts, \u0219i partenerul s\u0103u Merck au anun\u021bat c\u0103 vaccinul lor pe baz\u0103 de ARN mesager a reu\u0219it s\u0103 previn\u0103 recidiva sau r\u0103sp\u00e2ndirea cancerului la pacien\u021bii cu melanom de risc ridicat. Aceast\u0103 posibil\u0103 descoperire ar putea prelungi via\u021ba a sute de mii de persoane afectate de aceast\u0103 form\u0103 agresiv\u0103 de cancer de piele.<\/p>\n<p>\u00cen acela\u0219i timp, Agen\u021bia American\u0103 pentru Alimente \u0219i Medicamente (FDA) a aprobat luna trecut\u0103 un tratament pentru tumorile pancreatice, un progres important \u00een lupta \u00eempotriva uneia dintre cele mai letale forme de cancer.<\/p>\n<p>Autorit\u0103\u021bile chineze au aprobat pentru prima dat\u0103 administrarea terapiei CAR-T pacien\u021bilor str\u0103ini \u00een 2021. De c\u00e2nd a \u00eenceput s\u0103 ofere acest tratament, \u00een 2023, Spitalul SinoUnited din Shanghai a tratat aproximativ 36 de pacien\u021bi din 12 \u021b\u0103ri, potrivit dr. Kathy Shi, fondatoarea \u0219i directoarea executiv\u0103 a spitalului. Shi, cardiolog cu specializare postdoctoral\u0103 la Universitatea Emory din Atlanta, a precizat c\u0103 majoritatea acestor pacien\u021bi sunt acum vindeca\u021bi de cancer.<\/p>\n<p>Pe m\u0103sur\u0103 ce vestea s-a r\u0103sp\u00e2ndit, Spitalul SinoUnited sus\u021bine c\u0103 a primit pacien\u021bi proveni\u021bi de la MD Anderson, Clinica Mayo \u0219i Spitalul Johns Hopkins din Baltimore. Shi afirm\u0103 c\u0103 spitalul a \u00eenregistrat, de asemenea, o cre\u0219tere a solicit\u0103rilor din Statele Unite, Canada, Europa \u0219i Asia de Sud-Est.<\/p>\n<p>\u201eAcum un an, discutam frecvent cu pacien\u021bi chinezi care c\u0103utau tratament \u00een str\u0103in\u0103tate\u201d, a declarat Xuan Linli, \u0219eful sec\u021biei de oncologie medical\u0103 de la Spitalul Jiahui. \u201eAcum, tot mai mul\u021bi pacien\u021bi din str\u0103in\u0103tate solicit\u0103 consulta\u021bii la noi.\u201d<\/p>\n<p>publicitate&#8221;); background-position: center center; background-repeat: no-repeat;&#8221;&gt;<\/p>\n<p>Terapiile CAR-T sunt studiate \u00een Statele Unite \u00eenc\u0103 din anii 1980, iar \u00een China din anii 1990 <\/p>\n<p>Un moment de cotitur\u0103 a avut loc \u00een 2012, c\u00e2nd Emily Whitehead, originar\u0103 din Pennsylvania \u0219i \u00een v\u00e2rst\u0103 de 6 ani la acea vreme, a devenit primul copil care a \u00eenvins leucemia \u00een urma acestui tratament. (Aceasta este acum student\u0103 la Universitatea din Pennsylvania, la doar c\u00e2\u021biva pa\u0219i de locul unde a urmat terapia CAR-T.)<\/p>\n<p> <a class=\"related-inline svelte-78g0vl\" data-gtrack=\"{&quot;event&quot;:&quot;utm_click&quot;,&quot;data&quot;:{&quot;event_category&quot;:&quot;article_related&quot;}}\" href=\"https:\/\/adevarul.ro\/stiri-externe\/in-lume\/china-a-construit-un-lift-de-288-de-metri-pentru-2553919.html\" title=\"Alt articol de interes pentru tine\" rel=\"nofollow noopener\" target=\"_blank\"> China a construit un lift de 288 de metri pentru copiii unui sat izolat. Mergeau trei ore p\u00e2n\u0103 la \u0219coal\u0103, iar acum urc\u0103 \u00een doar 50 de secunde <\/a><\/p>\n<p>Terapia CAR-T r\u0103m\u00e2ne un tratament de ni\u0219\u0103 \u00een oncologie, deoarece poate fi utilizat\u0103 doar pentru un num\u0103r limitat de tipuri de cancer. \u00cen prezent, tratamentul CAR-T este administrat, de regul\u0103, doar dup\u0103 ce alte terapii au e\u0219uat, par\u021bial din cauza posibilelor efecte secundare, precum inflama\u021biile provocate de perfuzia celular\u0103.<\/p>\n<p> Ce ofer\u0103 \u00een plus China <\/p>\n<p>Pacien\u021bii aleg China nu doar din cauza costurilor reduse ale tratamentului, ci \u0219i pentru c\u0103 spitalele interna\u021bionale din \u021bar\u0103 ofer\u0103 o gam\u0103 larg\u0103 de servicii medicale, un factor esen\u021bial, av\u00e2nd \u00een vedere c\u0103 terapia CAR-T poate necesita \u00eengrijire intensiv\u0103 \u0219i interven\u021bia unor speciali\u0219ti precum cardiologi \u0219i neurologi.<\/p>\n<p>Deoarece terapia CAR-T presupune un tratament celular personalizat pentru fiecare pacient, capacitatea Chinei de a produce aceste terapii \u00een doar c\u00e2teva zile, \u00een laboratoare aflate la scurt\u0103 distan\u021b\u0103 de Shanghai, \u00eei ofer\u0103 un avantaj fa\u021b\u0103 de \u021b\u0103rile unde timpul de a\u0219teptare este mai mare.<\/p>\n<p>publicitate&#8221;); background-position: center center; background-repeat: no-repeat;&#8221;&gt;<\/p>\n<p>Posibilitatea unui tratament imediat \u00een China o face o op\u021biune atractiv\u0103 pentru pacien\u021bii care lupt\u0103 cu forme agresive de cancer.<\/p>\n<p>Bronkhorst \u0219i Walters descriu, de asemenea, servicii pentru pacien\u021bi superioare celor g\u0103site \u00een alte \u021b\u0103ri analizate, inclusiv sprijin pentru ob\u021binerea vizelor medicale \u0219i un nivel mai ridicat de competen\u021b\u0103 \u00een limba englez\u0103 din partea personalului medical.<\/p>\n<p>Walters a spus, citat de WSJ, c\u0103 s-a sim\u021bit lini\u0219tit dup\u0103 o convorbire video cu hematologul Lily Zhou, de la Spitalul SinoUnited, care \u0219i-a f\u0103cut studiile postdoctorale la Universitatea California, San Francisco.<\/p>\n<p>\u00cen Noua Zeeland\u0103, \u201eaveam impresia c\u0103 m\u0103 documentasem mai mult \u0219i \u0219tiam mai multe despre boal\u0103 dec\u00e2t medicii cu care vorbeam\u201d, a spus Walters. \u201eDar ea are at\u00e2ta experien\u021b\u0103&#8230; A fost pl\u0103cut s\u0103 vorbesc cu cineva care \u0219tia exact ce face.\u201d<\/p>\n<p> \\n  const _iprc = performance.now();\\n\\u003C\/script>\\n\\n\\u003Cscript class=\\&#8221;optanon-category-C0004\\&#8221; type=\\&#8221;text\/plain\\&#8221;>\\nconsole.log(\\&#8221;*** cookieconsent done:\\&#8221;, Math.round(performance.now() &#8211; _iprc) \/ 1000);\\n  gtag(&#8216;event&#8217;, &#8216;cookieconsent&#8217;, {\\n    name: &#8216;load&#8217;,\\n    value: Math.round(performance.now() &#8211; _iprc) \/ 1000\\n  });\\n\\u003C\/script>\\n\\u003C!&#8211; END PERFORMANCE COOKIE PRO &#8211;>\\n\\n{{#unless context.ads_disabled}}\\n\\n\\u003Cscript class=\\&#8221;optanon-category-C0004\\&#8221; type=\\&#8221;text\/plain\\&#8221; src=\\&#8221;\/\/a.teads.tv\/page\/99553\/tag\\&#8221; async=\\&#8221;true\\&#8221;>\\u003C\/script>\\n{{\/unless}}\\n\\n\\u003Cdiv data-ad=\\&#8221;adevarul.ro_728x90_sticky_display_bottom_adevarul_bottom_center_leaderboard\\&#8221; data-devices=\\&#8221;m:0,t:1,d:1\\&#8221;   class=\\&#8221;demand-supply\\&#8221;>\\u003C\/div>\\n\\n{{#if context.content}}\\n\\n{{#unless context.ads_disabled}}\\n\\u003Cscript class=\\&#8221;optanon-category-C0004\\&#8221; type=\\&#8221;text\/plain\\&#8221; src=\\&#8221;https:\/\/cnt.trvdp.com\/js\/1544\/6545.js\\&#8221;>\\u003C\/script>\\n{{\/unless}}\\n\\n\\n{{\/if}}\\n\\n\\n&#8221;,&#8221;html_mobile&#8221;:&#8221;\\n\\n\\n\\u003C!&#8211; CHECK PERFORMANCE COOKIE PRO &#8211;>\\n\\u003Cscript>\\n  const _iprc = performance.now();\\n\\u003C\/script>\\n\\n\\u003Cscript class=\\&#8221;optanon-category-C0004\\&#8221; type=\\&#8221;text\/plain\\&#8221;>\\nconsole.log(\\&#8221;*** cookieconsent done:\\&#8221;, Math.round(performance.now() &#8211; _iprc) \/ 1000);\\n  gtag(&#8216;event&#8217;, &#8216;cookieconsent&#8217;, {\\n    name: &#8216;load&#8217;,\\n    value: Math.round(performance.now() &#8211; _iprc) \/ 1000\\n  });\\n\\u003C\/script>\\n\\u003C!&#8211; END PERFORMANCE COOKIE PRO &#8211;>\\n\\n{{#unless context.ads_disabled}}\\n\\n\\n\\u003Cscript\\n  class=\\&#8221;optanon-category-C0004\\&#8221;\\n  type=\\&#8221;text\/plain\\&#8221;\\n  src=\\&#8221;\/\/a.teads.tv\/page\/99553\/tag\\&#8221;\\n  async=\\&#8221;true\\&#8221;\\n>\\u003C\/script>\\n\\n{{\/unless}} \\n\\n\\u003Cdiv\\n  data-ad=\\&#8221;adevarul.ro_sticky_mobile_bottom\\&#8221;\\n  data-devices=\\&#8221;m:1,t:0,d:0\\&#8221;\\n  class=\\&#8221;demand-supply\\&#8221;\\n>\\u003C\/div>\\n\\n{{#if context.content}} \\n\\n\\n{{#unless context.ads_disabled}}\\n\\u003Cscript class=\\&#8221;optanon-category-C0004\\&#8221; type=\\&#8221;text\/plain\\&#8221; src=\\&#8221;https:\/\/cnt.trvdp.com\/js\/1544\/6545.js\\&#8221;>\\u003C\/script>\\n{{\/unless}}\\n\\n{{\/if}}\\n\\n&#8221;},&#8221;updated_at&#8221;:&#8221;2025-11-01T11:31:21.462Z&#8221;},&#8221;AdPosition_head&#8221;:{&#8222;data&#8221;:{&#8222;custom_fields&#8221;:{},&#8221;for_desktop&#8221;:true,&#8221;for_mobile&#8221;:true,&#8221;html_desktop&#8221;:&#8221;\\u003Cmeta name=\\&#8221;profitshareid\\&#8221; content=\\&#8221;934cd37887433d585a2a227ef0576fcc\\&#8221; \/>\\n\\n\\n\\n{{#unless context.ads_disabled}}\\n\\n\\n{{#if context.content}}\\n\\u003Cscript type=\\&#8221;text\/plain\\&#8221; class=\\&#8221;optanon-category-C0004\\&#8221; src=\\&#8221;https:\/\/jsc.mgid.com\/site\/960965.js\\&#8221; async>\\u003C\/script>\\n\\n\\n\\u003Cscript type=\\&#8221;text\/plain\\&#8221; class=\\&#8221;optanon-category-C0004\\&#8221;>\\n  (function () {\\n    if (document.location.pathname.indexOf(&#8222;https:\/\/adevarul.ro\/ghid-de-cumparaturi&#8221;) === 0) {\\n      return;\\n    }\\n\\n    const s = document.createElement(\\&#8221;script\\&#8221;);\\n    s.src = \\&#8221;https:\/\/srv.divee.ai\/storage\/v1\/object\/public\/sdk\/divee.sdk.latest.js\\&#8221;;\\n    s.setAttribute(\\&#8221;data-project-id\\&#8221;, \\&#8221;4428864e-2da6-4fef-a83c-c16c2dfe86d9\\&#8221;);\\n    s.async = true;\\n    document.head.appendChild(s);\\n  })();\\n\\u003C\/script>\\n\\n\\n\\n\\n\\n{{\/if}}\\n\\n\\u003Cscript>\\n  window.teads_analytics = window.teads_analytics || {};\\n  window.teads_analytics.analytics_tag_id = \\&#8221;PUB_26459\\&#8221;;\\n  window.teads_analytics.share = window.teads_analytics.share || function() {\\n    ;(window.teads_analytics.shared_data = window.teads_analytics.shared_data || []).push(arguments)\\n  };\\n\\u003C\/script>\\n\\u003Cscript type=\\&#8221;text\/plain\\&#8221; class=\\&#8221;optanon-category-C0004\\&#8221; src=\\&#8221;https:\/\/a.teads.tv\/analytics\/tag.js\\&#8221;>\\u003C\/script>\\n\\n\\n{{#unless context.features.nolivesupply}}\\n\\u003Cscript async data-cfasync=\\&#8221;false\\&#8221; type=\\&#8221;text\/plain\\&#8221; class=\\&#8221;optanon-category-C0004\\&#8221; src=\\&#8221;https:\/\/live.demand.supply\/up.js\\&#8221;>\\u003C\/script>\\n{{\/unless}}\\n\\n\\u003Cscript type=\\&#8221;text\/plain\\&#8221; class=\\&#8221;optanon-category-C0004\\&#8221; src=\\&#8221;https:\/\/pagead2.googlesyndication.com\/pagead\/js\/adsbygoogle.js?client=ca-pub-3345426167175409\\&#8221; crossorigin=\\&#8221;anonymous\\&#8221;>\\u003C\/script>\\n\\n \\u003Cscript type=\\&#8221;text\/plain\\&#8221; class=\\&#8221;optanon-category-C0004\\&#8221; src=\\&#8221;https:\/\/terrific.live\/terrific-sdk.js\\&#8221; storeid=\\&#8221;iN6X0VPTDIicsVPKX6p0\\&#8221;>\\u003C\/script>\\n\\n{{\/unless}}\\n\\n\\u003Cstyle>\\n.google-adposition > div {\\n  flex-grow: 1;\\n}\\n\\n.google-adposition:has(iframe) {\\n    background-image: none !important;\\n}\\n\\n.menu-fixed .menu .headContainer .google-auto-placed {\\n    display: none;\\n}\\n\\narticle header .title .google-auto-placed {\\n    display: none;\\n}\\n\\n#onetrust-banner-sdk #onetrust-accept-btn-handler {\\n        margin-bottom: 10px;\\n    }\\n\\n    #onetrust-banner-sdk #onetrust-reject-all-handler {\\n        visibility: hidden;\\n    }\\n\\n\\u003C\/style>\\n\\n \\u003C!&#8211; Facebook Pixel Code &#8211;>\\u003Cscript type=\\&#8221;text\/plain\\&#8221; class=\\&#8221;optanon-category-C0002\\&#8221;>!function(f,b,e,v,n,t,s){if(f.fbq)return;n=f.fbq=function(){n.callMethod?n.callMethod.apply(n,arguments):n.queue.push(arguments)};if(!f._fbq)f._fbq=n;n.push=n;n.loaded=!0;n.version=&#8217;2.0&#8242;;n.queue=[];t=b.createElement(e);t.async=!0;t.src=v;s=b.getElementsByTagName(e)[0];s.parentNode.insertBefore(t,s)}(window,document,&#8217;script&#8217;,&#8217;https:\/\/connect.facebook.net\/en_US\/fbevents.js&#8217;); fbq(&#8216;init&#8217;, &#8216;1346397800155390&#8217;); fbq(&#8216;track&#8217;, &#8216;PageView&#8217;);\\u003C\/script>\\u003Cnoscript> \\u003Cimg height=\\&#8221;1\\&#8221; width=\\&#8221;1\\&#8221; src=\\&#8221;https:\/\/www.facebook.com\/tr?id=1346397800155390&#038;ev=PageView&#038;noscript=1\\&#8221;\/>\\u003C\/noscript>\\u003C!&#8211; End Facebook Pixel Code &#8211;>\\n\\n\\u003C!&#8211; alternativeAds &#8211;>\\n&#8221;,&#8221;html_mobile&#8221;:&#8221;\\u003Cmeta name=\\&#8221;profitshareid\\&#8221; content=\\&#8221;934cd37887433d585a2a227ef0576fcc\\&#8221; \/>\\n\\n\\n{{#unless context.ads_disabled}}\\n\\n{{#if context.content}}\\n\\u003Cscript type=\\&#8221;text\/plain\\&#8221; class=\\&#8221;optanon-category-C0004\\&#8221; src=\\&#8221;https:\/\/jsc.mgid.com\/site\/960965.js\\&#8221; async>\\u003C\/script>\\n\\n\\u003Cscript type=\\&#8221;text\/plain\\&#8221; class=\\&#8221;optanon-category-C0004\\&#8221;>\\n  (function () {\\n    if (document.location.pathname.indexOf(&#8222;https:\/\/adevarul.ro\/ghid-de-cumparaturi&#8221;) === 0) {\\n      return;\\n    }\\n\\n    const s = document.createElement(\\&#8221;script\\&#8221;);\\n    s.src = \\&#8221;https:\/\/srv.divee.ai\/storage\/v1\/object\/public\/sdk\/divee.sdk.latest.js\\&#8221;;\\n    s.setAttribute(\\&#8221;data-project-id\\&#8221;, \\&#8221;4428864e-2da6-4fef-a83c-c16c2dfe86d9\\&#8221;);\\n    s.async = true;\\n    document.head.appendChild(s);\\n  })();\\n\\u003C\/script>\\n\\n{{\/if}}\\n\\n\\u003Cscript>\\n  window.teads_analytics = window.teads_analytics || {};\\n  window.teads_analytics.analytics_tag_id = \\&#8221;PUB_26459\\&#8221;;\\n  window.teads_analytics.share = window.teads_analytics.share || function() {\\n    ;(window.teads_analytics.shared_data = window.teads_analytics.shared_data || []).push(arguments)\\n  };\\n\\u003C\/script>\\n\\u003Cscript type=\\&#8221;text\/plain\\&#8221; class=\\&#8221;optanon-category-C0004\\&#8221; src=\\&#8221;https:\/\/a.teads.tv\/analytics\/tag.js\\&#8221;>\\u003C\/script>\\n\\n{{#unless context.features.nolivesupply}}\\n\\u003Cscript async data-cfasync=\\&#8221;false\\&#8221; type=\\&#8221;text\/plain\\&#8221; class=\\&#8221;optanon-category-C0004\\&#8221; src=\\&#8221;https:\/\/live.demand.supply\/up.js\\&#8221;>\\u003C\/script>\\n{{\/unless}}\\n\\n\\u003Cscript type=\\&#8221;text\/plain\\&#8221; class=\\&#8221;optanon-category-C0004\\&#8221; src=\\&#8221;https:\/\/terrific.live\/terrific-sdk.js\\&#8221; storeid=\\&#8221;iN6X0VPTDIicsVPKX6p0\\&#8221;>\\u003C\/script>\\n\\n{{\/unless}}\\n\\u003Cstyle>\\n\\n.google-adposition:has(iframe) {\\n    background-image: none !important;\\n}\\n\\n.menu-fixed .menu .headContainer .google-auto-placed {\\n    display: none;\\n}\\n\\narticle header .title .google-auto-placed {\\n    display: none;\\n}\\n\\n#onetrust-banner-sdk #onetrust-accept-btn-handler {\\n        margin-bottom: 10px;\\n    }\\n\\n    #onetrust-banner-sdk #onetrust-reject-all-handler {\\n        visibility: hidden;\\n    }\\n\\u003C\/style>\\n&#8221;},&#8221;updated_at&#8221;:&#8221;2026-07-22T15:44:05.196Z&#8221;}},&#8221;last_changed&#8221;:&#8221;2026-09-09T10:45:09.417Z&#8221;,&#8221;page&#8221;:{&#8222;created_at&#8221;:&#8221;2026-09-01T11:41:23.049Z&#8221;,&#8221;created_by&#8221;:1,&#8221;custom_fields&#8221;:{},&#8221;domain&#8221;:&#8221;adevarul.ro&#8221;,&#8221;id&#8221;:99,&#8221;last_published_at&#8221;:&#8221;2026-09-01T11:41:24.572Z&#8221;,&#8221;name&#8221;:&#8221;Content layout (article)&#8221;,&#8221;published&#8221;:1,&#8221;s3_hash&#8221;:&#8221;a5e0764cf3bce051367545eab1538b4619e8ecb9&#8243;,&#8221;slug&#8221;:null,&#8221;title&#8221;:&#8221;Content layout&#8221;,&#8221;type&#8221;:&#8221;layout&#8221;,&#8221;updated_at&#8221;:&#8221;2022-07-21T08:27:20.732Z&#8221;,&#8221;version_id&#8221;:272},&#8221;path&#8221;:&#8221;\/stiri-externe\/china\/de-ce-aleg-tot-mai-multi-pacienti-occidentali-2554895.html&#8221;,&#8221;pathArray&#8221;:[&#8222;&#8221;,&#8221;stiri-externe&#8221;,&#8221;china&#8221;,&#8221;de-ce-aleg-tot-mai-multi-pacienti-occidentali-2554895.html&#8221;],&#8221;type&#8221;:&#8221;content&#8221;,&#8221;url&#8221;:&#8221;https:\/\/adevarul.ro\/stiri-externe\/china\/de-ce-aleg-tot-mai-multi-pacienti-occidentali-2554895.html&#8221;,&#8221;features&#8221;:{},&#8221;query&#8221;:{},&#8221;domain_config&#8221;:{&#8222;MISC&#8221;:{&#8222;logo&#8221;:{&#8222;width&#8221;:320,&#8221;height&#8221;:50}},&#8221;SYSTEM_TAGS&#8221;:[&#8222;noads&#8221;,&#8221;nocomments&#8221;,&#8221;sex&#8221;,&#8221;advert&#8221;,&#8221;advertorial&#8221;,&#8221;video&#8221;,&#8221;galerie&#8221;,&#8221;live&#8221;,&#8221;foto&#8221;,&#8221;exclusiv&#8221;,&#8221;analiza&#8221;,&#8221;interviu&#8221;,&#8221;reportaj&#8221;,&#8221;breaking news&#8221;],&#8221;default&#8221;:{&#8222;lang&#8221;:&#8221;ro&#8221;,&#8221;domain&#8221;:&#8221;adevarul.ro&#8221;,&#8221;alternateDomain&#8221;:&#8221;adevarul-ro.adh.reperio.news&#8221;,&#8221;friendlyName&#8221;:&#8221;Adev\u0103rul&#8221;,&#8221;logoURL&#8221;:&#8221;https:\/\/adevarul.ro\/favicon-144-precomposed.png&#8221;}},&#8221;client&#8221;:{&#8222;is_mobile&#8221;:false}}<\/p>\n","protected":false},"excerpt":{"rendered":"Shanghaiul devine o destina\u021bie tot mai c\u0103utat\u0103, datorit\u0103 costurilor mai mici dec\u00e2t \u00een Occident \u0219i progreselor \u00eenregistrate \u00een&hellip;\n","protected":false},"author":2,"featured_media":293381,"comment_status":"","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"footnotes":"","_share_on_mastodon":"0"},"categories":[14],"tags":[97,80547,96,532,80548,125,80549,41,40,38,39,6420,80546,40347],"class_list":["post-293380","post","type-post","status-publish","format-standard","has-post-thumbnail","category-afaceri","tag-afaceri","tag-biotehnologie","tag-business","tag-cancer","tag-car-t","tag-china","tag-imunoterapie","tag-ro","tag-romana","tag-romania","tag-romanian","tag-shanghai","tag-terapii-oncologice","tag-turism-medical"],"share_on_mastodon":{"url":"https:\/\/pubeurope.com\/@ro\/117240685511812955","error":""},"_links":{"self":[{"href":"https:\/\/www.europesays.com\/ro\/wp-json\/wp\/v2\/posts\/293380","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.europesays.com\/ro\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.europesays.com\/ro\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/ro\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/ro\/wp-json\/wp\/v2\/comments?post=293380"}],"version-history":[{"count":0,"href":"https:\/\/www.europesays.com\/ro\/wp-json\/wp\/v2\/posts\/293380\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/ro\/wp-json\/wp\/v2\/media\/293381"}],"wp:attachment":[{"href":"https:\/\/www.europesays.com\/ro\/wp-json\/wp\/v2\/media?parent=293380"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.europesays.com\/ro\/wp-json\/wp\/v2\/categories?post=293380"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.europesays.com\/ro\/wp-json\/wp\/v2\/tags?post=293380"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}